Home
>
National Drug Code (NDC)
>
Ceftazidime
Ceftazidime - 25021-127-20 - (ceftazidime)
Drug Information of Ceftazidime
| Product NDC: | 25021-127 |
| Proprietary Name: | Ceftazidime |
| Non Proprietary Name: | ceftazidime |
| Active Ingredient(s): | 1 g/1 & nbsp; ceftazidime |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ceftazidime
| Product NDC: | 25021-127 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062640 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080515 |
Package Information of Ceftazidime
| Package NDC: | 25021-127-20 |
| Package Description: | 25 VIAL in 1 CARTON (25021-127-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Information of Ceftazidime
| NDC Code | 25021-127-20 |
| Proprietary Name | Ceftazidime |
| Package Description | 25 VIAL in 1 CARTON (25021-127-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 25021-127 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ceftazidime |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20080515 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | CEFTAZIDIME |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
